Positive effect of Diamyd® is supported in new scientific article
Diamyd Medical (Nasdaq First North, Stockholm, DMYD B) today announced that a meta-analysis of previously published clinical studies shows that the diabetes vaccine Diamyd® with great probability reduces the loss of C-peptide, a measure of endogenous insulin production, by 15-20%. The analysis is made by internationally leading researchers in type 1 diabetes, and has been published in the journal Diabetologia. Diamyd Medical has previously announced, by press release February 2, 2015, that the basis for the now confirmed results was published in an abstract for a scientific conference.In an